We are live on ! Find out more
HLA

Hamilton Lane Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 14.17%
This Fund
S&P 500
This Quarter Est. Return
-2.56%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$178M
AUM Growth
-$50.2M
Cap. Flow
-$40M
Cap. Flow %
-22.54%
Top 10 Hldgs %
85.22%
Holding
55
New
2
Increased
3
Reduced
11
Closed
24

Top Buys

Rank Stock Value
1
GRNT icon
Granite Ridge Resources
GRNT
+$32.3M
2
NU icon
Nu Holdings
NU
+$6.23M
3
RSKD icon
Riskified
RSKD
+$2.23M
4
CXM icon
Sprinklr
CXM
+$1.09M
5
MNDY icon
monday.com
MNDY
+$1.06M

Sector Composition

Rank Sector Weight
1 Energy 28.88%
2 Financials 28.74%
3 Technology 28.42%
4 Consumer Discretionary 5.52%
5 Consumer Staples 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVLV icon
26
Evolv Technologies
EVLV
$991M
$477K 0.27%
98,249
-251
-0.3% -$1.55K
NEWR
27
DELISTED
New Relic, Inc.
NEWR
$379K 0.21%
4,424
GTM
28
ZoomInfo Technologies
GTM
$976M
$367K 0.21%
22,370
-181,561
-89% -$3.71M
ROVR
29
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$273K 0.15%
43,605
-932,114
-96% -$5.56M
HUMA icon
30
Humacyte
HUMA
$177M
$64.1K 0.04%
21,893
-30,800
-58% -$102K
DTIL icon
31
Precision BioSciences
DTIL
$180M
$27K 0.02%
2,637
AI icon
32
C3.ai
AI
$1.43B
-9,382
Closed -$342K
CHPT icon
33
ChargePoint
CHPT
$139M
-3,246
Closed -$571K
DNB
34
DELISTED
Dun & Bradstreet
DNB
-3,348,574
Closed -$38.7M
DNLI icon
35
Denali Therapeutics
DNLI
$3.74B
-52,129
Closed -$1.54M
DOCU
36
DocuSign
DOCU
$10.3B
-14,565
Closed -$744K
ENVX icon
37
Enovix
ENVX
$873M
-33,278
Closed -$525K
ESTC icon
38
Elastic
ESTC
$6.71B
-15,632
Closed -$1M
GH icon
39
Guardant Health
GH
$21.6B
-10,660
Closed -$382K
GTLB icon
40
GitLab
GTLB
$5.72B
-33,505
Closed -$1.71M
IKT icon
41
Inhibikase Therapeutics
IKT
$341M
-13,802
Closed -$49.8K
NTRA icon
42
Natera
NTRA
$37.9B
-7,145
Closed -$348K
OKTA icon
43
Okta
OKTA
$24B
-27,508
Closed -$1.91M
PINS icon
44
Pinterest
PINS
$13.4B
-58,057
Closed -$1.59M
RXRX icon
45
Recursion Pharmaceuticals
RXRX
$1.59B
-96,474
Closed -$721K
SEMR
46
DELISTED
Semrush
SEMR
-48,828
Closed -$467K
SNOW icon
47
Snowflake
SNOW
$102B
-20,475
Closed -$3.6M
TXG icon
48
10x Genomics
TXG
$6.02B
-18,731
Closed -$1.05M
XPEV icon
49
XPeng
XPEV
$12.3B
-16,903
Closed -$227K
XYZ
50
Block Inc
XYZ
$48.3B
-4,317
Closed -$287K

Similar funds

Hamilton Lane Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Hamilton Lane Advisors held 55 positions worth $178M, down 22% from $228M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Hamilton Lane Advisors withdrew a net $40M in Q3 2023, closing 24 positions and reducing 11 holdings. Its most notable exit was Dun & Bradstreet, an estimated $38.7M position sold in full.

By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 11% a quarter earlier, followed by Financials and Technology.

Against the trend, Hamilton Lane Advisors opened a new position in Nu Holdings worth $6.04M.

  • Hamilton Lane Advisors's largest Q3 2023 buy was Nu Holdings: 832,464 shares worth $6.04M.
  • Hamilton Lane Advisors added most to Granite Ridge Resources in Q3 2023, an estimated $32.3M increase.
  • Hamilton Lane Advisors's biggest Q3 2023 reduction was Rover Group, Inc. Class A Common Stock, cutting an estimated $5.56M.
  • Hamilton Lane Advisors fully exited Dun & Bradstreet in Q3 2023, selling an estimated $38.7M.
  • Hamilton Lane Advisors's ten largest holdings make up 85% of its $178M portfolio in Q3 2023.
  • Hamilton Lane Advisors opened 2 new positions and closed 24 in Q3 2023.
  • Hamilton Lane Advisors's portfolio value fell 22% quarter-over-quarter to $178M.

Based on Hamilton Lane Advisors's 13F filing for Q3 2023, filed 7 Nov 2023.